{"text": ["FDA", "To", "Miss", "Action", "Dates", "For", "AbbVie's", "Upadacitinib", "Application", "For", "Psoriatic", "Arthritis,", "Ankylosing", "Spondylitis"], "created_at": "2021-06-25 17:33:23"}
{"text": ["AbbVie", "Provides", "Update", "Regarding", "RINVOQ\u00ae", "(upadacitinib)", "in", "Psoriatic", "Arthritis", "and", "Ankylosing", "Spondylitis", "in", "the", "U.S."], "created_at": "2021-06-25 12:30:00"}
{"text": ["3", "High-Yield", "Stocks", "With", "Secure", "Payouts"], "created_at": "2021-06-25 11:50:45"}
{"text": ["AbbVie", "Slips", "on", "FDA", "Delay", "in", "Arthritis-Drug", "Action", "Dates"], "created_at": "2021-06-25 10:42:00"}
{"text": ["AbbVie", "Inc.", "(NYSE:ABBV)", "is", "Finding", "Balance", "between", "Dividends", "and", "Growth"], "created_at": "2021-06-25 10:16:27"}
{"text": ["CHMP", "Recommends", "Approval", "of", "RINVOQ\u00ae", "(upadacitinib)", "for", "the", "Treatment", "of", "Atopic", "Dermatitis"], "created_at": "2021-06-25 06:30:00"}
